Does United Healthcare Cover Weight Loss Drugs? Rules and Costs

UnitedHealthcare does cover weight loss drugs for some members, but coverage is far from automatic. Whether your plan pays for Wegovy, Zepbound, Saxenda, Contrave, or an older appetite suppressant depends almost entirely on what kind of UnitedHealthcare plan you have and, for employer coverage, whether your employer chose to add the weight loss drug benefit. Every covered medication requires prior authorization and must be paired with diet and exercise.¹

Who Actually Gets Coverage

UnitedHealthcare treats weight loss drug coverage as an optional benefit, not a standard one. The answer for you turns on three categories.

Employer-sponsored plans. These make up most of UHC’s commercial membership, and the employer decides whether weight loss drugs are included. Many employers do not cover them at all.² When an employer opts in, UHC administers the benefit through its prior authorization program.

ACA marketplace and individual plans. Coverage here is uncommon. A Kaiser Family Foundation review of 2024 federal marketplace data found that only about 1% of marketplace drug plans covered Wegovy, while 82% covered Ozempic, which has the same active ingredient but is approved for diabetes.³ UHC notes that California, New Mexico, North Dakota, and New York have state rules that may require some level of weight loss drug coverage as an Essential Health Benefit.¹

Medicare Part D. Federal law has long barred Part D plans, including UHC’s, from paying for drugs prescribed for weight loss.⁴ That changed on a limited basis in mid-2026 through a new federal demonstration described further down.

Which Weight Loss Drugs Are on the List

When an employer plan does cover weight loss drugs, UHC’s prior authorization program includes a broad set of anti-obesity medications:¹

Wegovy (semaglutide), injection and tablet forms
Zepbound (tirzepatide)
Saxenda (liraglutide)
Contrave (naltrexone/bupropion)
Qsymia (phentermine/topiramate)
Xenical (orlistat)
Older appetite suppressants: phentermine (including Adipex-P and Lomaira), benzphetamine, diethylpropion, and phendimetrazine

Clinical Requirements for Approval

Every weight loss drug UHC covers goes through prior authorization. Your prescriber submits clinical documentation, and the plan has to approve it before the pharmacy will fill it. Under UHC’s pharmacy policy effective May 2026, the general criteria are consistent across most of the covered drugs:¹

A BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea.
Use alongside diet, exercise, or a behavioral support program. The prescriber must attest to this lifestyle modification.
Age minimums: Wegovy, Saxenda, Qsymia, and Xenical are available starting at age 12; most other medications require the patient to be older than 16.

UHC does not generally require documentation of past failed diet attempts, and the standard weight loss program does not impose step therapy, so you don’t have to fail a cheaper drug first. One state carve-out: on North Dakota fully insured Essential Health Benefit plans, initial approval requires a BMI of 40 or higher instead of 30.¹

You Have to Keep Losing Weight to Stay Approved

Each drug has its own initial authorization window and the amount of weight you need to lose to get reauthorized:¹

Wegovy: initial 5 months; reauthorization requires at least 5% weight loss from baseline and lasts 12 months.
Zepbound: initial 6 months; reauthorization requires at least 5% weight loss and lasts 12 months.
Saxenda: initial 4 months; reauthorization requires at least 4% weight loss and lasts 12 months.
Contrave: initial 4 months; reauthorization requires at least 5% weight loss and lasts 12 months.
Qsymia: initial 4 months; reauthorization requires at least 3% weight loss and lasts 12 months.
Older appetite suppressants (phentermine, benzphetamine, diethylpropion, phendimetrazine): initial 3 months; reauthorization requires at least 5% weight loss.

If you don’t hit the weight loss target in the initial window, UHC may deny continued coverage of that medication.

The Coaching Requirement on Many Employer Plans

For self-insured employers that cover GLP-1 drugs, UHC offers Total Weight Support, a program launched in 2024 that pairs medication coverage with behavioral coaching. UHC’s position is that the drugs alone are not a long-term solution: its data shows fewer than half of GLP-1 users remain on the medication after one year, and stopping often leads to regaining baseline weight within 18 months.²

Employers that participate pick one of two coaching vendors: Real Appeal Rx or WeightWatchers for Business.⁵ Members may have to enroll in or actively engage with the vendor program as a condition of getting the drug covered. California fully insured groups specifically require participation in a motivation-based wellness program along with prior authorization before drug coverage activates.⁶ More than one-third of employers who cover weight loss drugs now require coaching participation, up from about 10% the prior year.²

What You’ll Pay

Copay and coinsurance amounts for weight loss drugs are not published in UHC’s clinical policies. Cost-sharing depends on the benefit design your employer or plan chose.¹ Check your plan documents or call the number on your member ID card for the specifics.

Without insurance, these drugs are expensive. Wegovy carries a typical cash price around $1,842 for a 30-day supply.⁷ Zepbound has a manufacturer list price of $1,086 for a 28-day supply, though Eli Lilly’s direct-purchase and discount pricing ranges from $299 to $449 per month depending on dose. Eligible patients with commercial insurance may pay as little as $25 per fill using the Zepbound manufacturer savings card, though people on Medicare, Medicaid, or other government insurance are not eligible for those programs.⁸

Medicare: The New GLP-1 Bridge Program

Starting July 1, 2026, the Centers for Medicare and Medicaid Services launched the Medicare GLP-1 Bridge Program, a temporary demonstration that provides weight loss drug access outside the standard Part D benefit.⁹ The Bridge Program covers Wegovy (injection and tablets), Zepbound (KwikPen form only), and Foundayo (tablet).

To qualify, you must be 18 or older and meet one of three BMI tiers:¹⁰

BMI of 35 or more; or
BMI between 30 and 34.99 with qualifying health conditions; or
BMI between 27 and 29.99 with prediabetes, a prior heart attack or stroke, or peripheral artery disease.

People who already receive a GLP-1 drug through standard Part D for conditions like type 2 diabetes, sleep apnea, or fatty liver disease are not eligible for the Bridge, since those uses are already covered.¹⁰

The copay is a flat $50 per fill. That $50 does not count toward your Part D deductible or out-of-pocket maximum, and Medicare’s Extra Help program cannot reduce it. Prior authorization is required, and your prescriber must certify that you are participating in a diet and exercise lifestyle program.¹⁰

The demonstration runs through December 31, 2027. CMS had announced a broader model called BALANCE that would have let Part D plans provide permanent weight loss coverage starting in 2027, but a May 2026 announcement delayed BALANCE indefinitely. Permanent Part D coverage of weight loss drugs would require Congressional action.¹¹

If UnitedHealthcare Denies Your Weight Loss Drug

You have formal appeal rights if a prior authorization or coverage request is denied. For Medicare Part D members, the process has three main steps:¹²

Coverage determination: submitted by phone, online through OptumRx, by mail, or by fax. UHC must respond within 72 hours, or within 24 hours if your prescriber certifies that waiting could harm your health.
Level 1 appeal: you have 65 days to file in writing. UHC must respond within 7 calendar days for a standard appeal or 72 hours for an expedited one.
Level 2 appeal: if the first appeal fails, the case goes to an Independent Review Entity.

You can also request a formulary exception if the drug is restricted or excluded on your plan. The prescriber generally has to explain why alternative medications would not be as effective or would cause side effects.¹² For employer-sponsored self-insured plans governed by ERISA, request a written denial and follow the appeal process in your Explanation of Benefits, typically within a 60-day window.¹³

How to Confirm What Your Plan Covers

Because coverage varies so widely, the only reliable way to know is to check your own plan. Call the number on the back of your member ID card, log into your UHC account online, or ask your prescriber to submit a prior authorization request to see whether the drug is approved. If your coverage comes through work, your HR or benefits department can confirm whether the weight loss drug benefit has been elected and whether a coaching program like Total Weight Support is attached to it.

1
UnitedHealthcare Provider. Prior Authorization Weight Loss Medications
2
UnitedHealthcare. Sustainable Weight Management
3
KFF. Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans
4
UnitedHealthcare. Prescription Drug Plans
5
UnitedHealthcare. Total Weight Support
6
Word & Brown. Weight Loss Drugs (GLP-1) Coverage
7
SingleCare. Does United Healthcare Cover Wegovy for Weight Loss
8
GoodRx. Zepbound Cost for Weight Loss
9
CMS. Medicare GLP-1 Bridge
10
Medicare.gov. Weight Loss Drugs
11
Medicare Rights Center. GLP-1 Weight Loss Drug Demonstration Begins July 2026
12
UnitedHealthcare. Prescription Drug Appeals
13
Obesity Action Coalition. Appealing a Denial